Answers are grounded in this paper and cite their sources.
Intercellular mitochondrial transfer may reallocate metabolic and signalling capacity across breast-tumour ecosystems, but evidence varies by donor, cargo and method. We synthesise direct breast-cancer and cross-system studies using a direction- and cargo-resolved framework. Stress may create transfer-permissive interfaces, whereas active transfer requires donor-resolved cargo in recipient cells. We define evidence standards, identify causal boundaries for therapy resistance and propose direction-selective block–restore strategies.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: